Selamawit Addissie
Internal Medicine
4924 Campbell Boulevard, Suite 200
Suite 200
Nottingham, MD 21236
Suite 200
Nottingham, MD 21236
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 10, 2018
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.
Journal: The AAPS journal
Published: June 15, 2016
Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo.
Journal: Cellular & molecular immunology
Published: July 27, 2015
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors.
Journal: Molecular cancer therapeutics
Published: June 25, 2015
Showing 1-6 of 6
Last Updated: 09/26/2026